Immucell (ICCC) Stock: Buy, Sell, or Hold?
ICCC - Immucell Corp
$9.72
-0.19 (-1.93%)
▼
5d:
-2.77%
30d:
-11.44%
90d:
-0.17%
BUY
HIGH Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Aug 13, 2026
0d
Get Alerted When ICCC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: ICCC shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
✅ BUY SIGNAL: ICCC shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
In-depth Analysis How we analyze
Valuation Analysis: ICCC is currently trading at $9.72, which is considered oversold relative to its 30-day fair value range of $9.75 to $10.74.
Technical Outlook: Technically, ICCC is in a uptrend. The price is currently testing key support at $9.63. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: ICCC scores 88/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $14.00 (+41.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ICCC is in a uptrend. The price is currently testing key support at $9.63. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: ICCC scores 88/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $14.00 (+41.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$9.75 -
$10.74
Company Quality Score
69/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (88/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 41.2% below Wall St target ($14.00)
- BULLISH: Bottoming setup score 88/100 — corrected, stabilizing, and turning up
Trading Range Analysis
30-Day Trading Range
$9.75 -
$10.74
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$9.63
Resistance Level
$10.30
Current Trend
Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Wall Street Target
$14.00
(+41.2%)
Revenue Growth (YoY)
11.5%
Earnings Growth (YoY)
259.9%
Profit Margin
2.6%
Share & Embed Analysis
Last updated: September 11, 2026 3:28 PM ET
Data refreshes hourly during market hours. Next update: 4:28 PM
Data refreshes hourly during market hours. Next update: 4:28 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ICCC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$91 | 58 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$285 | 56 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$36 | 45 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$34 | 60 BUY |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$109 | 57 HOLD |
